About Raregen
Raregen is a company based in Durham (United States) founded in 2018 was acquired by Liquidia in June 2020. Raregen offers products and services including YUTREPIA, L606, and PRINT Technology. Raregen operates in a competitive market with competitors including Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
- Headquarter Durham, United States
-
Sectors
Financial ServicesHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Liquidia Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raregen
Raregen offers a comprehensive portfolio of products and services, including YUTREPIA, L606, and PRINT Technology.
Inhaled treatment for pulmonary arterial hypertension.
Drug candidate for pulmonary hypertension associated with lung disease.
Proprietary system for enhancing drug efficacy in cardiopulmonary care.
People of Raregen
Unlock access to complete
Funding Insights of Raregen
Detailed funding history for Raregen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Raregen
Raregen has secured backing from 1 investor. Prominent investors backing the company include Liquidia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Engineered particles & films for life and material sciences applications
|
Locked | Locked | Locked |
Investor details for Raregen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Raregen
Investment portfolio details for Raregen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Raregen
Detailed financials for Raregen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raregen Comparisons
Peer comparison for Raregen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Raregen
Raregen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heartland Dental, AOK, Keplr Vision, The Chartis Group and Sterigenics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of healthcare consulting services
|
|
| Locked | Locked | Locked |
Medical insurance services for patients and employees are provided.
|
|
| Locked | Locked | Locked |
Business support and supply chain management services are offered.
|
|
| Locked | Locked | Locked |
Advisory services are offered to U.S. healthcare providers.
|
|
| Locked | Locked | Locked |
Provider of comprehensive sterilization solutions and expert consulting services
|
|
| Locked | Locked | Locked |
Contract manufacturing is provided for life sciences and diagnostics reagents.
|
Detailed competitors of Raregen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raregen
Complete news archive for Raregen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raregen
Raregen was founded in 2018.
Raregen is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Roger Jeffs is the current CEO of Raregen.
Raregen was founded in 2018 and is headquartered in Durham, United States. Consulting services focused on strategy planning and investment are offered to clients in the healthcare sector. Operations emphasize advisory support for sector-specific challenges, including market analysis and financial guidance. Leadership is provided by CEO Roger Jeffs, with expertise centered on healthcare innovation and growth strategies.
Raregen's top competitors include Qualicorp, Heartland Dental and Argonautms.
Raregen offers YUTREPIA, L606, and PRINT Technology.
Raregen has 1 investor. Key investors include Liquidia.